As stakeholders firmly committed to fostering patient access to affordable medicines and pharmaceutical competition, we would like to thank you for introducing the bicameral and bipartisan Creating and Restoring Equal Access to Equivalent Samples (“CREATES”) Act.
Press Release: While improved adherence to diabetes medications is associated with higher drug costs, it also is associated with lower inpatient, outpatient and emergency room costs, according to a study in this month’s Journal of Managed Care & Specialty Pharmacy (JMCP)
Press Release: While improved adherence to diabetes medications is associated with higher drug costs, it also is associated with lower inpatient, outpatient and emergency room costs, according to a study in this month’s Journal of Managed Care & Specialty Pharmacy (JMCP).
The Academy of Managed Care Pharmacy (AMCP) thanks the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) for the opportunity to provide comments in response to the request for information (RFI) for Medicare Advantage (MA) and Medicare Part D programs included in the “Announcement of Calendar Year (CY) 2018 Medicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and Final Call Letter and Request for Information” released on April 3, 2017.
Sponsored AMCP webinar that focused on the impact of MACRA provisions on health care providers and population medication management by pharmacists, physicians, and nurses.
The undersigned organizations thank the Food and Drug Administration (FDA) for the opportunity to provide comments in response to “Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities—Questions and Answers [FDA-2016-D-1307]” as published in the Federal Register on January 19, 2017.